drugset
drugset / Trial / NCT00533195

Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis

NCT00533195 ↗

Phase 3 Completed 20 enrolled Medical University of Vienna
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to compare the efficacy, tolerability and remission duration of UVA 1 therapy versus 5-MOP UVA photochemotherapy for patients with severe generalized atopic dermatitis.

Timeline

Start
2007-10
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator BERGAPTEN Small molecule 1.2 mg/kg Oral

Indications

atopic eczema